Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy Assessment
Authors
Suiwen Ye (ORCID: https://orcid.org/0009-0001-3185-6448)
Di Cheng (ORCID: https://orcid.org/0000-0001-9388-376X)
National Key Research and Development Program of China
Science and Technology Planning Project of Guangdong Province
Basic and Applied Basic Research Foundation of Guangdong Province
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy Assessment
Suiwen Ye, Di Cheng, Junyan Wu, Xiaozhi Lv et al.
Citations
4 citations
Journal
Cancer Medicine
Topics
Pancreatic and Hepatic Oncology Research
Field-Weighted Citation Impact (FWCI)
1.13
article
Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy Assessment
Suiwen Ye, Di Cheng, Junyan Wu, Xiaozhi Lv, Xiuping Lai, Liuning Li, Herui Yao, Zhi-Hua Li, Huixin Xu, Jingshu Wang
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
Cancer MedicineVol. 14(1)
Institutions
Sun Yat-sen University (CN), Sun Yat-sen Memorial Hospital (CN)
Funders
Tencent, National Natural Science Foundation of China, Sun Yat-sen University, National Key Research and Development Program of China, Science and Technology Planning Project of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province